Tech's Top Movers

The Nasdaq 100, a tech-heavy index, finished last week up 1.05% to close at 1,952.63. According to CNBC's weekly markets review, high hopes for the monthly jobs report, due this Friday, appears to be rubbing off on investors. They've shown particular enthusiasm for tech issues such as Apple (Nasdaq: AAPL  ) , which was trading near its 52-week high as of this writing.

Pops and drops
Here's a closer look at the index's top movers, both to the upside and downside. Returns are calculated from the Nasdaq 100's closing price on Friday, March 19.

Last week's winners:

Company

Percentage Gain

CAPS Stars
(Out of 5)

Garmin (Nasdaq: GRMN  )

10.5%

***

Lam Research (Nasdaq: LRCX  )

7.73%

***

SanDisk Corp.

7.59%

****

Wynn Resorts

6.80%

*

Urban Outfitters

6.69%

**

Sources: Capital IQ, Motley Fool CAPS, Yahoo! Finance.

Last week's losers:

Company

Percentage Loss

CAPS Stars
(Out of 5)

Genzyme (Nasdaq: GENZ  )

(10.8%)

****

Gilead Sciences (Nasdaq: GILD  )

(5.29%)

*****

Expeditors International (Nasdaq: EXPD  )

(5.02%)

*****

Apollo Group (Nasdaq: APOL  )

(4.80%)

**

Xilinx

(4.51%)

***

Sources: Capital IQ, Motley Fool CAPS, Yahoo! Finance.

A weekly tour of tech
The week's top stock, Garmin, rose sharply after management adopted a plan to buy back as much as $300 million worth of shares under the purview of what's known as a 10b5-1 plan.

The structure allows an independent broker, operating under guidelines established by management, to repurchase shares when the stock trades within certain price ranges. It's a fascinating move, and one that could give investors a window into what executives believe is cheap when it comes to Garmin's stock.

Some Fools believe the shares are already too cheap to ignore. "Boosting dividend to $1.50 this quarter. No debt. Leader in its space, especially aviation, sports and boating," wrote All-Star investor MoPicks earlier this month.

"Strong growth ahead in aftermarket auto GPS. Moving HQ to Switzerland by end of June 2010, which forces end of shareholders' rights plan. Could be a takeover target, but should perform well regardless," this highly rated Fool concluded.

The week's top loser, Genzyme, suffered a setback when the Food and Drug Administration ordered a consent decree on a problem plant.

"Essentially, the consent decree gives the FDA authority to appoint a third party to inspect the plant and confirm that it's in compliance ... In addition to any lost time dealing with inspectors, Genzyme has to pick up the tab through fees and fines," wrote Foolish colleague Brian Orelli in covering the news. No wonder investors are running for hills.

What do you have to say about these stocks? Other tech issues? Log into Motley Fool CAPS today and let your voice be heard. You can also weigh in using the comments box below.

Get your clicks with related Foolishness:

Apple is a Motley Fool Stock Advisor selection. Apollo Group is an Inside Value pick. Try any of our Foolish newsletter services free for 30 days.

Fool contributor Tim Beyers is also a member of the Motley Fool Rule Breakers stock-picking team. He didn't own shares in any of the companies mentioned in this article at the time of publication. Check out Tim's portfolio holdings and Foolish writings, or connect with him on Twitter as @milehighfool. The Motley Fool has created a covered strangle position on Expeditors International and is also on Twitter as @TheMotleyFool. Its disclosure policy is a mover. And a shaker.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1139081, ~/Articles/ArticleHandler.aspx, 10/2/2014 6:50:39 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement